Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2023-12-27
Original market date: See footnote 1
1993-01-01
Product name:
VIVOTIF
DIN:
00885975
Product Monograph/Veterinary Labelling:
Date:
2023-12-27
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BAVARIAN NORDIC AS
Philip Heymans Alle 3
Hellerup
--
Denmark
2900
Class:
Human
Dosage form(s):
Capsule (Enteric-Coated)
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Schedule D
American Hospital Formulary Service (AHFS): See footnote 3
80:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
J07AP01 TYPHOID, ORAL, LIVE ATTENUATED
Active ingredient group (AIG) number:See footnote5
0165582001
| Active ingredient(s) | Strength |
|---|---|
| SALMONELLA TYPHI TY21A LIVE ATTENUATED | 10000000000 CFU |